[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-novo-nordisk-foundation-challenge-programme-2027-advancing-next-generation-2026":3,"similar-novo-nordisk-foundation-challenge-programme-2027-advancing-next-generation-2026":23},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":10,"deadline":11,"deadline_note":12,"duration":13,"trl":11,"relevance":11,"why_relevant":11,"early_career":14,"consortium":15,"first_seen":16,"last_updated":11,"update_note":11,"status":17,"stages":18,"call_frequency":11,"next_call_expected":11,"source_url":7,"created_at":19,"updated_at":19,"eligible_countries":20,"description":22,"seo_summary":11},"novo-nordisk-foundation-challenge-programme-2027-advancing-next-generation-2026","Challenge Programme 2027: Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections","Novo Nordisk Foundation","https:\u002F\u002Fnovonordiskfonden.dk\u002Fen\u002Fgrant\u002Fchallenge-programme-2027-advancing-next-generation-amr-diagnostics-for-lower-respiratory-tract-infections\u002F","DKK 30–75 million per grant (ca. EUR 4–10 million); total pool ca. EUR 20 million",4000000,10000000,null,"2-stage process: Stage 1 expression of interest, then shortlisted applicants invited to Stage 2 full proposal. Specific dates not stated in this segment.","6 years",false,"Required — 2–4 research groups (main applicant + 1–3 co-applicants); at least one applicant must be based at a Danish institution; main applicant must be at a European (EU, Schengen Area, or UK) university, hospital, or non-profit","Wed May 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)","open","2-stage: Stage 1 expression of interest → Stage 2 full proposal + online presentation to review panel","Wed May 20 2026 05:40:05 GMT+0000 (Coordinated Universal Time)",[21],"DK","Early-stage proof-of-concept research on rapid, minimally invasive, affordable LRTI diagnostics and AMR susceptibility testing for point-of-care use in global settings. Research must be anchored at a research institution or non-profit; for-profit product development is ineligible. Main applicant must be tenured\u002Ftenure-track at a European (EU\u002FSchengen\u002FUK) institution with ≥75% commitment; at least one applicant must be ≥75% employed at a Danish institution. Industry partners may collaborate but cannot receive funding.",{"grants":24},[25,30,34,39,44],{"id":26,"name":27,"funder":6,"deadline":28,"budget":29},"novo-nordisk-foundation-interdisciplinary-synergy-programme-2026-2026-05","Interdisciplinary Synergy Programme 2026","2026-05-20T00:00:00.000Z","Up to DKK 19.4 million per grant",{"id":31,"name":32,"funder":6,"deadline":28,"budget":33},"nnf-synergy-2026","Novo Nordisk Foundation Interdisciplinary Synergy Programme 2026","Up to DKK 19.4M (~€2.6M)",{"id":35,"name":36,"funder":6,"deadline":37,"budget":38},"novo-nordisk-foundation-steno-collaborative-grants-2026-06","Steno Collaborative Grants","2026-06-02T00:00:00.000Z","DKK 1M–DKK 10M per grant (total pool up to DKK 30M)",{"id":40,"name":41,"funder":6,"deadline":42,"budget":43},"novo-nordisk-foundation-non-diabetic-endocrinology-collaborative-grants-20-2026-06","Non-Diabetic Endocrinology Collaborative Grants 2026","2026-06-03T00:00:00.000Z","DKK 5M–10M per grant (total pool up to DKK 53M)",{"id":45,"name":46,"funder":6,"deadline":47,"budget":48},"novo-nordisk-foundation-project-grants-in-endocrinology-and-metabolism-nor-2026-06","Project grants in Endocrinology and Metabolism – Nordic Region","2026-06-04T00:00:00.000Z","Up to DKK 4.5 million per grant"]